2025 Conference on Retroviruses and Opportunistic Infections

San Francisco, California | March 9-12, 2025

Please refresh the page to ensure that you view the latest version.

View PDF | View FlipBook
Version 4 | Updated April 18, 2025

View PDF | View FlipBook
Version 4 | Updated April 18, 2025

Abstracts from CROI 2025 are published in Topics in Antiviral Medicine Volume 33, Issue 1. Click here to view the issue, including information on how to cite CROI abstracts.

Abstracts and electronic posters from CROI 2014 to 2025 are available.

In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, the Scientific Program Committee, Community Liaison Subcommittee, invited speakers, and program staff) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.

The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”

This information is intended to make the audience aware of speaker and contributor financial relationships with ineligible companies, enabling the audience members to form their own judgments about such associations. Each author, contributor, or person in control of the content in the CME activity is required to complete this financial disclosure declaration.

In accordance with IAS–USA policy, the IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenters and planners/reviewers will also be available in the slides prior to the presentation of educational content.

On-demand webcasts are available at https://www.croiwebcasts.org/.

CROI conference materials (including, but not limited to, the CROI Program Guide, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Any part of CROI materials (such as an abstract as formatted in the CROI Abstract eBook or poster as presented in the Platform) cannot be published without prior CROI approval and approval of the authors. Permission to replicate or reproduce these elements must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). However, study data are the property of the author(s) and study sponsors as relevant. For more information, please email CROIabstracts@iasusa.org.

Material available through www.iasusa.org, www.CROIconference.org, the CROI Webcast site(s), CROI mobile app(s), CROI virtual conference platforms, and any other vehicles through which IAS-USA or the CROI Foundation distribute CROI materials (some of which may be protected by copyright or trademark) are the property of the CROI Foundation, IAS-USA, and their licensors. For more details and permissions requests, see Website Policies and Copyright (CROIconference.org)

Last Modified: Apr 18, 2025 @ 3:16 pm